{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:38:18Z","timestamp":1781829498588,"version":"3.54.5"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.jaad.2021.07.067","type":"journal-article","created":{"date-parts":[[2021,8,8]],"date-time":"2021-08-08T05:23:20Z","timestamp":1628400200000},"page":"131-137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Efficacy of nonexcisional treatment modalities for superficially invasive and in situ squamous cell carcinoma: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"87","author":[{"given":"Jacob R.","family":"Stewart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret E.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry D.","family":"Brewer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jaad.2021.07.067_bib1","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/0190-9622(92)70144-5","article-title":"Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip: implications for treatment modality selection","volume":"26","author":"Rowe","year":"1992","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.jaad.2021.07.067_bib2","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1111\/j.1524-4725.2012.02574.x","volume":"38","author":"Connolly","year":"2012","journal-title":"Dermatol Surg"},{"issue":"2","key":"10.1016\/j.jaad.2021.07.067_bib3","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1001\/archderm.143.2.264","article-title":"Response of Bowen disease to ALA-PDT using a single and a 2-fold illumination scheme","volume":"143","author":"de Haas","year":"2007","journal-title":"Arch Dermatol"},{"issue":"suppl 2","key":"10.1016\/j.jaad.2021.07.067_bib4","first-page":"67","article-title":"Fractionated illumination improves the outcome in the treatment of precancerous lesions with photodynamic therapy","volume":"32","author":"Puizina-Ivic","year":"2008","journal-title":"Coll Antropol"},{"issue":"4","key":"10.1016\/j.jaad.2021.07.067_bib5","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1046\/j.1365-2133.2000.03773.x","article-title":"Comparison of red and green light in the treatment of Bowen's disease by photodynamic therapy","volume":"143","author":"Morton","year":"2000","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2021.07.067_bib6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1001\/archderm.140.1.26","article-title":"Photodynamic therapy of multiple non-melanoma skin cancers with verteporfin and red light-emitting diodes: two-year results evaluating tumor response and cosmetic outcomes","volume":"140","author":"Lui","year":"2004","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2021.07.067_bib7","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1001\/archderm.142.6.729","article-title":"Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: results of a multicenter randomized trial","volume":"142","author":"Morton","year":"2006","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2021.07.067_bib8","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1046\/j.1365-2133.1996.d01-1076.x","article-title":"Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease","volume":"135","author":"Morton","year":"1996","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2021.07.067_bib9","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1365-2133.2006.07616.x","article-title":"Treatment of post-transplant premalignant skin disease: a randomized intrapatient comparative study of 5-fluorouracil cream and topical photodynamic therapy","volume":"156","author":"Perrett","year":"2007","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2021.07.067_bib10","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1046\/j.1365-2133.2003.05033.x","article-title":"Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen's disease","volume":"148","author":"Salim","year":"2003","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2021.07.067_bib11","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.jaad.2006.01.055","article-title":"Imiquimod 5% cream monotherapy for cutaneous squamous cell carcinoma in situ (Bowen's disease): a randomized, double-blind, placebo-controlled trial","volume":"54","author":"Patel","year":"2006","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2021.07.067_bib12","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1097\/DSS.0000000000001608","article-title":"Enhancement of\u00a0photodynamic therapy for Bowen's disease using plum-blossom needling to augment drug delivery","volume":"44","author":"Wu","year":"2018","journal-title":"Dermatol Surg"},{"issue":"1","key":"10.1016\/j.jaad.2021.07.067_bib13","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/bjd.12627","article-title":"A randomized trial comparing methyl aminolaevulinate photodynamic therapy with and without Er:YAG ablative fractional laser treatment in Asian patients with lower extremity Bowen disease: results from a 12-month follow-up","volume":"170","author":"Ko","year":"2014","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2021.07.067_bib14","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/jdv.15109","article-title":"Short incubation fractional CO2 laser-assisted photodynamic therapy vs. conventional photodynamic therapy in field-cancerized skin: 12-month follow-up results of a randomized intraindividual comparison study","volume":"33","author":"Vrani","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.jaad.2021.07.067_bib15","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1001\/jamadermatol.2016.4463","article-title":"Effect of methyl aminolevulinate photodynamic therapy with and without ablative fractional laser treatment in patients with microinvasive squamous cell carcinoma: a randomized clinical trial","volume":"153","author":"Choi","year":"2017","journal-title":"JAMA Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2021.07.067_bib16","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1007\/s10103-015-1754-1","article-title":"Photodynamic therapy in combination with CO2 laser for the treatment of Bowen's disease","volume":"30","author":"Cai","year":"2015","journal-title":"Lasers Med Sci"},{"issue":"1","key":"10.1016\/j.jaad.2021.07.067_bib17","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1524-4725.2011.02240.x","article-title":"Light-emitting diode laser versus pulsed dye laser-assisted photodynamic therapy in the treatment of actinic keratosis and Bowen's disease","volume":"38","author":"Kim","year":"2012","journal-title":"Dermatol Surg"},{"issue":"3","key":"10.1016\/j.jaad.2021.07.067_bib18","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1600-0781.2012.00658.x","article-title":"Comparison of the efficacy of ALA-PDT using an excimer-dye laser (630 nm) and a metal-halide lamp (600 to 740 nm) for treatment of Bowen's disease","volume":"28","author":"Mizutani","year":"2012","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.jaad.2021.07.067_bib19","first-page":"CD007281","article-title":"Interventions for cutaneous Bowen's disease","volume":"6","author":"Bath-Hextall","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.jaad.2021.07.067_bib20","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jaad.2019.06.030","article-title":"Treatments for primary squamous cell carcinoma and squamous cell carcinoma in situ of the skin: a systematic review and network meta-analysis: summary of an Agency for Healthcare Research and Quality Comparative Effectiveness Review","volume":"82","author":"Drucker","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2021.07.067_bib21","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1001\/archdermatol.2009.291","article-title":"Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: a systematic review","volume":"145","author":"Love","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2021.07.067_bib22","doi-asserted-by":"crossref","first-page":"f6153","DOI":"10.1136\/bmj.f6153","article-title":"Interventions for non-metastatic squamous cell carcinoma of the skin: systematic review and pooled analysis of observational studies","volume":"347","author":"Lansbury","year":"2013","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.jaad.2021.07.067_bib23","first-page":"107","article-title":"Improving the quality of reports of meta-analyses of randomized controlled trials: the QUOROM statement","volume":"74","author":"Moher","year":"2000","journal-title":"Rev Esp Salud Publica"},{"key":"10.1016\/j.jaad.2021.07.067_bib24","series-title":"Cochrane handbook (version 5) sections relating to new risk-of-bias tool","author":"Higgins","year":"2007"},{"key":"10.1016\/j.jaad.2021.07.067_bib25","series-title":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","author":"Wells","year":"2019"},{"issue":"1","key":"10.1016\/j.jaad.2021.07.067_bib26","first-page":"1","article-title":"Closing the gap between methodologists and end-users: R as a computational back-end","volume":"49","author":"Wallace","year":"2012","journal-title":"J Stat Softw"},{"issue":"1","key":"10.1016\/j.jaad.2021.07.067_bib27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2307\/3001666","article-title":"The combination of estimates from different experiments","volume":"10","author":"Cochran","year":"1954","journal-title":"Biometrics"},{"issue":"7414","key":"10.1016\/j.jaad.2021.07.067_bib28","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.jaad.2021.07.067_bib29","series-title":"Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice","first-page":"471","article-title":"Understanding and applying the results of a systematic review and meta-analysis","author":"Murad","year":"2015"},{"issue":"1","key":"10.1016\/j.jaad.2021.07.067_bib30","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1001\/archdermatol.2007.28","article-title":"Systematic reviews: grading recommendations and evidence quality","volume":"144","author":"Robinson","year":"2008","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2021.07.067_bib31","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/DSS.0000000000001400","article-title":"Factors influencing squamous cell carcinoma in situ recurrence and implications for treatment choice","volume":"44","author":"Matsumoto","year":"2018","journal-title":"Dermatol Surg"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962221022787?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962221022787?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T23:03:41Z","timestamp":1759273421000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962221022787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S0190962221022787"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2021.07.067","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of nonexcisional treatment modalities for superficially invasive and in situ squamous cell carcinoma: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2021.07.067","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}